Glaucoma Therapeutics Market, by Disease Type (Primary Open Angle Glaucoma (POAG) and Primary Angle Closure Glaucoma (PACG)), by Drug Class (Alpha adrenergic Agonist, Beta Blockers, Prostaglandin Analogs, Carbonic Anhydrase Inhibitor, Cholinergic, Combined Medication, and Fixed-dose Combinations), by End Users (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, and Others), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Select a license type that suits your business needs
Single User License
US$ 4,500
US$ 3,500
Three thousand five hundred dollars
Frequently purchased
Multi User License
US$ 7,000
US$ 5,500
Five thousand five hundred dollars
Corporate User License
US$ 10,000
US$ 7,500
Seven thousand five hundred dollars
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients